Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Mar 9:6:95.
doi: 10.3389/fimmu.2015.00095. eCollection 2015.

Eliminating Schistosomes through Vaccination: What are the Best Immune Weapons?

Affiliations
Review

Eliminating Schistosomes through Vaccination: What are the Best Immune Weapons?

Cristina Toscano Fonseca et al. Front Immunol. .

Abstract

The successful development of vaccines depends on the knowledge of the immunological mechanisms associated with the elimination of the pathogen. In the case of schistosomes, its complex life cycle and the mechanisms developed to evade host immune system, turns the development of a vaccine against the disease into a very difficult task. Identifying the immunological effector mechanisms involved in parasite attrition and the major targets for its response is a key step to formulate an effective vaccine. Recent studies have described some promising antigens to compose a subunit vaccine and have pointed to some immune factors that play a role in parasite elimination. Here, we review the immune components and effector mechanisms associated with the protective immunity induced by those vaccine candidates and the lessons we have learned from the studies of the acquired resistance to infection in humans. We will also discuss the immune factors that correlate with protection and therefore could help to evaluate those vaccine formulations in clinical trials.

Keywords: effector mechanisms; immune response; protective immunity; schistosome vaccine; schistosomiasis.

PubMed Disclaimer

References

    1. Andre FE, Booy R, Bock HL, Clemens J, Datta SK, John TJ, et al. Vaccination greatly reduces disease, disability, death and inequity worldwide. Bull World Health Organ (2008) 86:140–6.10.2471/BLT.07.040089 - DOI - PMC - PubMed
    1. Oliveira SC, Fonseca CT, Cardoso FC, Farias LP, Leite LC. Recent advances in vaccine research against schistosomiasis in Brazil. Acta Trop (2008) 108:256–62.10.1016/j.actatropica.2008.05.023 - DOI - PubMed
    1. Gryseels B. Schistosomiasis. Infect Dis Clin North Am (2012) 26:383–97.10.1016/j.idc.2012.03.004 - DOI - PubMed
    1. Jenkins SJ, Hewitson JP, Jenkins GR, Mountford AP. Modulation of the host’s immune response by schistosome larvae. Parasite Immunol (2005) 27:385–93.10.1111/j.1365-3024.2005.00789.x - DOI - PMC - PubMed
    1. Novato-Silva E, Nogueira-Machado JA, Gazzinelli G. Schistosoma mansoni: comparison of the killing effect of granulocytes and complement with or without antibody on fresh and cultured schistosomula in vitro. Am J Trop Med Hyg (1980) 29:1263–7. - PubMed